上海交通大学学报（医学版）

上海交通大学学报（医学版） >

2024 , Vol. 44 >Issue 12: 1593 - 1600

DOI: https://doi.org/10.3969/j.issn.1674-8115.2024.12.013

综述

β-抑制蛋白1在炎症反应调控中作用的研究进展

  • 衣文婧 ,
  • 范宜璇 ,
  • 仇佳泰 ,
  • 付晓燕 ,
  • 刘梅芳
展开
  • 山东第二医科大学基础医学院免疫微环境与炎症性疾病研究特色实验室，潍坊 261053
衣文婧（2002—），女，本科生；电子信箱：2682445008@qq.com。
刘梅芳，电子信箱：lmf00719@163.com。

收稿日期: 2024-02-01

  录用日期: 2024-09-03

  网络出版日期: 2024-12-16

基金资助

国家自然科学基金(82000525);山东省大学生创新创业训练计划(S202310438068);山东省高等学校青创科技支持计划(2021KJ106);山东省自然科学基金(ZR2023MH359);山东省高等学校青创人才引育计划“免疫微环境与炎症性疾病研究创新团队”

收起

Research progress in the role of β-arrestin 1 in the regulation of inflammatory response

  • Wenjing YI ,
  • Yixuan FAN ,
  • Jiatai QIU ,
  • Xiaoyan FU ,
  • Meifang LIU
Expand
  • Key Laboratory of Immune Microenvironment and Inflammatory Disease Research, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261053, China
LIU Meifang, E-mail: lmf00719@163.com.

Received date: 2024-02-01

  Accepted date: 2024-09-03

  Online published: 2024-12-16

Supported by

National Natural Science Foundation of China(82000525);Shandong Provincial College Student Innovation and Entrepreneurship Training Program(S202310438068);Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province(2021KJ106);Natural Science Foundation of Shandong Province(ZR2023MH359);Shandong Provincial Higher Education Youth Talent Introduction Program "Immune Microenvironment and Inflammatory Disease Research Innovation Team"

Fold

摘要

炎症反应是机体应对感染或损伤等刺激时产生的系统性响应过程，与多种疾病的发生机制密切相关，并在疾病进展与转归过程中起着重要作用。正常情况下，炎症反应能够在机体受损不严重时做出响应并维持组织稳态；而在受到较严重的刺激时，失控的炎症反应往往会对机体造成严重危害。理想的炎症反应是在消除了炎症刺激后终止响应，因此有效调控炎症反应的程度和范围显得尤为重要。β-抑制蛋白1（β-arrestin 1，ARRB1）是一种多功能调节蛋白，在G蛋白偶联受体（G protein-coupled receptor，GPCR）和非GPCR介导的信号转导中发挥关键作用；同时，该蛋白还参与部分免疫细胞发育、分化等功能的调控。尽管ARRB1最初被认为是GPCR信号转导的终止子，可抑制炎症反应，但近年来的研究提示ARRB1在炎症反应中的作用较为复杂，具有抑制炎症和促进炎症的双重作用。基于此，该文回顾了近年来ARRB1与炎症反应的相关研究，详细阐述并讨论了ARRB1对信号通路转导和免疫细胞发育、分化功能的调控作用以及其调控炎症性疾病进展的作用机制，以期为炎症性疾病的临床精准治疗和药物效应靶点的筛选提供新思路。

关键词： β-抑制蛋白1; 抑制炎症作用; 促进炎症作用; 信号通路; 免疫细胞; 炎症因子

本文引用格式

衣文婧 , 范宜璇 , 仇佳泰 , 付晓燕 , 刘梅芳 . β-抑制蛋白1在炎症反应调控中作用的研究进展[J]. 上海交通大学学报（医学版）, 2024 , 44(12) : 1593 -1600 . DOI: 10.3969/j.issn.1674-8115.2024.12.013

Abstract

The inflammatory response is a systemic process produced by the body in response to stimulation such as infection or injury. The inflammatory response is closely related to the pathogenesis of various diseases, and plays an important role in the progression and outcome of diseases. Under normal conditions, the inflammatory response can maintain tissue homeostasis when the body is not seriously damaged. However, an uncontrolled inflammatory response that occurs when the body is subjected to more severe stimuli may often cause serious harm to the body. The termination of the ideal inflammatory response occurs after the elimination of the inflammatory stimulus. Therefore, it is particularly important to effectively modulate the extent and scope of the inflammatory response. β-arrestin 1 (ARRB1) is a multifunctional regulatory protein that plays a key role in G protein-coupled receptor (GPCR) and non-GPCR-mediated signal transduction. Meanwhile, this protein also participates in the regulation of some immune cell development, differentiation and other functions. Although ARRB1 was originally thought to be a terminator of GPCR signal transduction and can inhibit the inflammatory response, recent studies suggest that its role in inflammatory responses is complex, with dual anti-inflammatory and pro-inflammatory effects. Based on this, this article reviews the relevant research on ARRB1 and the inflammatory response in recent years, focusing on the regulatory role of ARRB1 in signaling pathway transduction and immune cell development and differentiation function, as well as its mechanism of action in regulating the progression of inflammatory diseases, in order to provide new insights for the clinical precision treatment of inflammatory diseases and the screening of drug effect targets.

Key words： β-arrestin 1 (ARRB1); anti-inflammatory role; pro-inflammatory role; signaling pathway; immune cell; inflammatory factor

参考文献

1 CHEN S Z, HUANG M Y, ZHANG L M, et al. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis[J]. Comput Struct Biotechnol J, 2024, 23: 369-383.
2 AGIRMAN G, YU K B, HSIAO E Y. Signaling inflammation across the gut-brain axis[J]. Science, 2021, 374(6571): 1087-1092.
3 SCHROEDER H T, DE LEMOS MULLER C H, HECK T G, et al. Heat shock response during the resolution of inflammation and its progressive suppression in chronic-degenerative inflammatory diseases[J]. Cell Stress Chaperones, 2024, 29(1): 116-142.
4 FURMAN D, CAMPISI J, VERDIN E, et al. Chronic inflammation in the etiology of disease across the life span[J]. Nat Med, 2019, 25(12): 1822-1832.
5 YING W, FU W X, LEE Y S, et al. The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities[J]. Nat Rev Endocrinol, 2020, 16(2): 81-90.
6 LI D J, TONG J, LI Y H, et al. Melatonin safeguards against fatty liver by antagonizing TRAFs-mediated ASK1 deubiquitination and stabilization in a β-arrestin-1 dependent manner[J]. J Pineal Res, 2019, 67(4): e12611.
7 DAWED A Y, MARI A, BROWN A, et al. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials[J]. Lancet Diabetes Endocrinol, 2023, 11(1): 33-41.
8 DEWIRE S M, AHN S, LEFKOWITZ R J, et al. β-arrestins and cell signaling[J]. Annu Rev Physiol, 2007, 69: 483-510.
9 LOVGREN A K, KOVACS J J, XIE T, et al. β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix[J]. Sci Transl Med, 2011, 3(74): 74ra23.
10 CHOI Y J, KIM J E, LEE S J, et al. Promotion of the inflammatory response in mid colon of complement component 3 knockout mice[J]. Sci Rep, 2022, 12(1): 1700.
11 张泉, 张梅. β-arrestin1在炎-癌转化中的研究进展[J]. 现代肿瘤医学, 2022, 30(15): 2864-2867.
11 ZHANG Q, ZHANG M. Research progress of β-arrestin1 in inflammation-induced carcinogenesis[J]. Journal of Modern Oncology, 2022, 30(15): 2864-2867.
12 MAFI A, KIM S K, GODDARD WA 3rd. The mechanism for ligand activation of the GPCR-G protein complex[J]. Proc Natl Acad Sci U S A, 2022, 119(18): e2110085119.
13 LEFKOWITZ R J, SHENOY S K. Transduction of receptor signals by β-arrestins[J]. Science, 2005, 308(5721): 512-517.
14 KO M J, CHIANG T, MUKADAM A A, et al. β-arrestin-dependent ERK signaling reduces anxiety-like and conditioned fear-related behaviors in mice[J]. Sci Signal, 2021, 14(694): eaba0245.
15 ZHANG Z, ZHONG X H, XIAO Y P, et al. MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation[J]. Oncol Rep, 2019, 41(1): 619-629.
16 LI J, WEI B, GUO A, et al. Deficiency of β-arrestin1 ameliorates collagen-induced arthritis with impaired TH17 cell differentiation[J]. Proc Natl Acad Sci U S A, 2013, 110(18): 7395-7400.
17 XU X, LEI Y M, CHEN L J, et al. Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target[J]. J Exp Clin Cancer Res, 2021, 40(1): 253.
18 RANJAN R, GUPTA P, SHUKLA A K. GPCR signaling: β-arrestins kiss and remember[J]. Curr Biol, 2016, 26(7): R285-R288.
19 OAKLEY R H, LAPORTE S A, HOLT J A, et al. Differential affinities of visual arrestin, β arrestin1, and β arrestin2 for G protein-coupled receptors delineate two major classes of receptors[J]. J Biol Chem, 2000, 275(22): 17201-17210.
20 CHEN K, ZHANG C H, LIN S L, et al. Tail engagement of arrestin at the glucagon receptor[J]. Nature, 2023, 620(7975): 904-910.
21 SUN L N, SU Y H, JIAO A J, et al. T cells in health and disease[J]. Signal Transduct Target Ther, 2023, 8(1): 235.
22 陈燕华, 蒋光洁, 郭维, 等. Arrb1基因敲除对小鼠T淋巴细胞发育的影响[J]. 中国细胞生物学学报, 2018, 40(3): 373-380.
22 CHEN Y H, JIANG G J, GUO W, et al. Effects of Arrb1 knockout on the development of mice T lymphocytes[J]. Chinese Journal of Cell Biology, 2018, 40(3): 373-380.
23 GUREVICH V V, GUREVICH E V. Arrestin makes T cells stop and become active[J]. EMBO J, 2014, 33(6): 531-533.
24 BJ?RGO E, TASKéN K. Novel mechanism of signaling by CD28[J]. Immunol Lett, 2010, 129(1): 1-6.
25 ABRAHAMSEN H, BAILLIE G, NGAI J, et al. TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling[J]. J Immunol, 2004, 173(8): 4847-4858.
26 SHI Y F, FENG Y, KANG J H, et al. Critical regulation of CD4+ T cell survival and autoimmunity by β-arrestin 1[J]. Nat Immunol, 2007, 8(8): 817-824.
27 GóMEZ-MELERO S, GARCíA-MACEIRA F I, GARCíA-MACEIRA T, et al. Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin[J]. BMC Biotechnol, 2021, 21(1): 41.
28 KUMAR R, THEISS A L, VENUPRASAD K. RORγt protein modifications and IL-17-mediated inflammation[J]. Trends Immunol, 2021, 42(11): 1037-1050.
29 CAO Y P, HE W, LI X P, et al. Rosiglitazone protects against acetaminophen-induced acute liver injury by inhibiting multiple endoplasmic reticulum stress pathways[J]. Biomed Res Int, 2022, 2022: 6098592.
30 LEI Y M, WAN S Z, LIU H L, et al. ARRB1 suppresses the activation of hepatic macrophages via modulating endoplasmic reticulum stress in lipopolysaccharide-induced acute liver injury[J]. Cell Death Discov, 2021, 7(1): 223.
31 WU B S, ZHOU Q, HE Z Q, et al. Protective effect of the Abelmoschus manihot flower extract on DSS-induced ulcerative colitis in mice[J]. Evid Based Complement Alternat Med, 2021, 2021: 7422792.
32 KANG S, NARAZAKI M, METWALLY H, et al. Historical overview of the interleukin-6 family cytokine[J]. J Exp Med, 2020, 217(5): e20190347.
33 FANG Y Q, JIANG Q L, LI S S, et al. Opposing functions of β-arrestin 1 and 2 in Parkinson's disease via microglia inflammation and Nprl3[J]. Cell Death Differ, 2021, 28(6): 1822-1836.
34 ZHANG Q, XU N, HU X, et al. Anti-colitic effects of Physalin B on dextran sodium sulfate-induced BALB/c mice by suppressing multiple inflammatory signaling pathways[J]. J Ethnopharmacol, 2020, 259: 112956.
35 MAO K, CHEN S, WANG Y, et al. β-arrestin1 is critical for the full activation of NLRP3 and NLRC4 inflammasomes[J]. J Immunol, 2015, 194(4): 1867-1873.
36 YANG Y D, GUO Y W, TAN S W, et al. β-arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling[J]. Nat Commun, 2015, 6: 7369.
37 ZHANG Z C, XU X L, TIAN W F, et al. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation[J]. J Hepatol, 2020, 72(5): 976-989.
38 ZHUANG L N, HU W X, XIN S M, et al. β-arrestin-1 protein represses adipogenesis and inflammatory responses through its interaction with peroxisome proliferator-activated receptor-γ (PPARγ)[J]. J Biol Chem, 2011, 286(32): 28403-28413.
39 TAO L, LIN X Y, TAN S W, et al. β-arrestin1 alleviates acute pancreatitis via repression of NF-κBp65 activation[J]. J Gastroenterol Hepatol, 2019, 34(1): 284-292.
40 WITHEROW D S, GARRISON T R, MILLER W E, et al. β-arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα[J]. Proc Natl Acad Sci U S A, 2004, 101(23): 8603-8607.
41 ZHENG F, XIAO F, YUAN Q H, et al. Penehyclidine hydrochloride decreases pulmonary microvascular endothelial inflammatory injury through a β-arrestin-1-dependent mechanism[J]. Inflammation, 2018, 41(5): 1610-1620.
42 FAN H K, LUTTRELL L M, TEMPEL G E, et al. β-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression[J]. Mol Immunol, 2007, 44(12): 3092-3099.
43 WANG M W, YANG Z, CHEN X, et al. Activation of PTH1R alleviates epididymitis and orchitis through Gq and β-arrestin-1 pathways[J]. Proc Natl Acad Sci U S A, 2021, 118(45): e2107363118.
44 SHU Y, WANG Y, LV W Q, et al. ARRB1-promoted NOTCH1 degradation is suppressed by oncomiR miR-223 in T-cell acute lymphoblastic leukemia[J]. Cancer Res, 2020, 80(5): 988-998.
Options
文章导航

/

〈 〉